Mundipharma to Launch Biosimilar Truxima in Europe

28.02.2017 - UK pharmaceutical group Mundipharma is gearing up to launch Truxima (rituximab), a biosimilar from South Korea’s Celltrion, for the treatment of certain cancers and inflammatory...